SLC1A5 and breast carcinoma: We examined mRNA and protein levels of several transmembrane Gln transporters such as SLC7A5/LAT1, SLC1A4/ASCT1, SLC1A5/ASCT2, SLC38A1/SNAT1 and SLC38A2/SNAT2 in a variety of breast cancer cell lines representing the luminal (ER+, HER2−; MCF-7 and T47D), HER2+ (SKBR3), basal-like (HCC1806; MDA-MB-468, 468) and claudin-low (MDA-MB-231, 231) molecular subtypes of breast cancer (Fig. 1a).